Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifecodes is a leading provider of molecular and antibody-based diagnostic solutions focused on the fields of transplant and transfusion medicine. Originally a pioneer in DNA fingerprinting, the company evolved into a specialist in Human Leukocyte Antigen (HLA) typing and antibody detection to improve donor-recipient matching. Its product portfolio includes Luminex-based assays for HLA typing, screening, and identification, as well as platelet antibody testing. Currently operating as a brand under Immucor (a Werfen company), Lifecodes' technologies are essential for reducing the risk of graft rejection in organ and bone marrow transplants. The company's products are used globally by histocompatibility and immunogenetics laboratories to ensure patient safety and transplant success.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifecodes.